Stage 4 pink eye in cattle represents the most advanced and economically damaging phase of Infectious Bovine Keratoconjunctivitis, demanding immediate intervention to prevent permanent vision loss. At this stage, the corneal ulceration has typically progressed to a state of severe necrosis, often accompanied by a significant anterior chamber reaction and potential rupture of the globe. Understanding the progression to this critical point is essential for implementing effective herd health strategies and mitigating substantial financial losses associated with decreased milk production, treatment costs, and culling.
Pathogenesis and Escalation to Stage 4
The disease process begins with the colonization of the ocular surface by *Moraxella bovis*, which adheres to the corneal epithelium using pili. Initial irritation causes lacrimation and photophobia, but if left unchecked, the bacteria produce cytotoxic exotoxins that destroy corneal cells. This leads to ulceration, and the inflammatory response attracts neutrophils and other immune cells. As the infection intensifies and the immune response becomes overwhelming, the condition escalates from early stages through to the structural compromise characteristic of stage 4, where the integrity of the cornea is critically threatened.
Clinical Signs Specific to Stage 4
By stage 4, the clinical presentation is dramatic and impossible to ignore. The cornea is typically opaque or white due to extensive necrosis and ulceration, often appearing almost like a milky lens. A significant corneal edema, or fluid buildup within the layers, may cause the eye to bulge slightly. The anterior chamber is deep and exhibits a severe fibrinoinflammatory reaction, sometimes with visible pus or hypopyon at the bottom. Intense uveitis causes the pupil to be irregular and poorly responsive to light, and the eye is usually extremely painful, leading to complete blindness in that eye.
Immediate Treatment Protocols
When stage 4 is identified, the primary goals are to control pain, prevent secondary infections, and attempt to preserve the structural integrity of the eye. Systemic antibiotics targeting *M. bovis*, such as long-acting oxytetracyclines, are crucial to address the systemic infection. However, the cornerstone of treatment is intensive topical therapy with broad-spectrum antibiotics and atropine ointment to dilate the pupil and relieve ciliary spasm. In severe cases, surgical intervention, such as a corneal transplant or temporary tarsorrhaphy, may be the only option to save the eye and prevent perforation.
